Phenominer Database Results (15 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Experiment Notes Record ID Study ID
WAG/Rij body weight 0.9% sodium chloride solution (1 ml) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass female 91 days-0 days 2 200.0 g 6.01 8.5 body weighing method 0.0 0 body weight 107015 3074
WAG/Rij body weight 0.9% sodium chloride solution (1 ml) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass male 91 days-0 days 2 326.0 g 18.03 25.5 body weighing method 0.0 0 body weight 107016 3074
WAG/Rij body weight azoxymethane (15 mg/kg) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass female 63 days 8 146.0 g 2.44 6.9 body weighing method 0.0 0 body weight 106989 3074
WAG/Rij body weight azoxymethane (15 mg/kg) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass male 56 days 4 203.0 g 4.9 9.8 body weighing method 0.0 0 body weight 106995 3074
WAG/Rij body weight azoxymethane (15 mg/kg) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass male 91 days-0 days 4 327.0 g 10.0 20.0 body weighing method 0.0 0 body weight 107010 3074
WAG/Rij percentage of study population developing colorectal tumors during a period of time azoxymethane (15 mg/kg) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. colorectal integrity trait female 266 days-0 days 4 0.0 % ex vivo light microscopy with immunohistochemistry 0.0 0 107069 3074
WAG/Rij percentage of study population developing colorectal tumors during a period of time azoxymethane (15 mg/kg) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. colorectal integrity trait male 224 days-0 days 4 50.0 % ex vivo light microscopy with immunohistochemistry 0.0 0 107070 3074
WAG/Rij body weight control condition Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass female 63 days 2 148.0 g 1.98 2.8 body weighing method 0.0 0 body weight 106979 3074
WAG/Rij body weight control condition Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass female 98 days-0 days 2 211.0 g 4.53 6.4 body weighing method 0.0 0 body weight 106980 3074
WAG/Rij body weight 0.9% sodium chloride solution (0.4 ml) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass male 56 days 2 178.0 g 5.02 7.1 body weighing method 0.0 0 body weight 106986 3074
WAG/Rij body weight 0.9% sodium chloride solution (0.4 ml) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass female 56 days 2 126.0 g 4.03 5.7 body weighing method 0.0 0 body weight 106985 3074
WAG/Rij body weight azoxymethane (15 mg/kg) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass female 91 days-0 days 4 195.0 g 6.25 12.5 body weighing method 0.0 0 body weight 107009 3074
WAG/Rij percentage of study population developing colorectal tumors during a period of time azoxymethane (15 mg/kg) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. colorectal integrity trait female 280 days-0 days 8 12.5 % ex vivo light microscopy with immunohistochemistry 0.0 0 107019 3074
WAG/Rij body weight azoxymethane (15 mg/kg) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass female 56 days 4 126.0 g 3.9 7.8 body weighing method 0.0 0 body weight 106994 3074
WAG/Rij body weight azoxymethane (15 mg/kg) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass female 98 days-0 days 8 198.0 g 2.76 7.8 body weighing method 0.0 0 body weight 107003 3074